Nuclear Medicine/Radiopharmaceuticals Market Size Is Predicted To Reach 4967 million $ By 2022: Worldwide Key players( Cardinal Health, Ge Healthcare , Curium, Lantheus Medical Imaging, Bayer, Bracco Imaging )

This report provides in depth study of “Nuclear Medicine Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Nuclear Medicine Market report also provides an in-depth survey of key players in the market organization.

Global Nuclear Medicine/Radiopharmaceuticals Market Overview:

The past four years, Nuclear Medicine/Radiopharmaceuticals market size to maintain the average annual growth rate of 5.93% from 3130 million $ in 2014 to 3720 million $ in 2017, As per the projections of the Market Analyst, Nuclear Medicine/Radiopharmaceuticals market size will be further expanded by 2022, The market size of the Nuclear Medicine/Radiopharmaceuticals will reach 4967 million $.

Request Report Sample@ https://www.businessindustryreports.com/sample-request/97134 .

Growth in this market can primarily be attributed to factors such as the increasing incidence and prevalence of target conditions such as cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99.

On the Basis of Type Segment, The nuclear medicine market is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals. Diagnostic radiopharmaceuticals have been further segmented into SPECT and PET radiopharmaceuticals. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, and other SPECT isotopes. In 2017, the Tc-99m segment accounted for the largest share of the nuclear medicine SPECT radiopharmaceuticals market. Tc-99m is used in a majority of diagnostic nuclear medicine procedures such as MPI, cardiac ventriculography, functional brain imaging, sentinel-node identification, immunoscintigraphy, blood pool labeling, sulfur colloid for spleen scan, and diagnosing various bone ailments.

On the Basis of Applications, the nuclear medicine market is segmented into diagnostic and therapeutic applications. The diagnostic applications are further segmented into SPECT applications and PET applications. Whereas the therapeutic applications are further segmented into thyroid, bone metastasis, lymphoma, endocrine tumors, and others (breast cancer, cervical cancer, GI tumors, and renal tumors). The SPECT application segment accounted for the largest share of the diagnostic nuclear medicine market by applications owing to the rising demand for cardiac imaging.

Regionally, North America is expected to account for the largest share of the nuclear medicine market in 2018, followed by Europe. The large share of this region can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the region.

Purchase this premium research report with 122 Pages and No. of Table of contents, List of table at https://www.businessindustryreports.com/buy-now/97134/single .

The market is segmented and projected on the basis of major key player’s:

1 Cardinal Health

2 Ge Healthcare (A Fully-Owned Subsidiary Of General )

3 Curium

4 Lantheus Medical Imaging

5 Bayer

6 Bracco Imaging

7 Eczacibasi-Monrol Nuclear Products

8 Nordion

9 Advanced Accelerator Applications

The Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into:

The Market is segmented and projected on the basis of major Region Segmentation

1 North America Country (United States, Canada)

2 South America

3 Asia Country (China, Japan, India, Korea)

4 Europe Country (Germany, UK, France, Italy)

5 Other Country (Middle East, Africa, GCC)

Grab Your Report at an Impressive Discount@ https://www.businessindustryreports.com/check-discount/97134 .

The Market is segmented and projected on the basis of Product Type Segmentation

1 Diagnostic Nuclear Medicine

2 Therapeutic Nuclear Medicine

The Market is segmented and projected on the basis of Application Segmentation

1 Diagnostic Applications

2 Therapeutic Applications

Key Questions Answered in this Report:

1 What will the market size be in 2022?

2 What are the key factors driving the Nuclear Medicine Market?

3 What are the challenges to market growth?

4 Who are the key players in Nuclear Medicine Market?

5 What are the market opportunities and threats faced by the key players?

TABLE OF CONTENTS

1 Nuclear Medicine/Radiopharmaceuticals Product Definition

2 Global Nuclear Medicine/Radiopharmaceuticals Market Manufacturer Share and Market Overview

3 Manufacturer Nuclear Medicine/Radiopharmaceuticals Business Introduction

4 Global Nuclear Medicine/Radiopharmaceuticals Market Segmentation (Region Level)

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.